TARSUS PHARMACEUTICALS INC (TARS)
US87650L1035 - Common Stock
ChartMill assigns a Buy % Consensus number of 87% to TARS. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 54.44. This target is 69.92% above the current price.
TARS was analyzed by 15 analysts. The buy percentage consensus is at 87. So analysts seem to be very confident about TARS.
In the previous month the buy percentage consensus was at a similar level.
TARS was analyzed by 15 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-03-06 | Jefferies | Maintains | Buy -> Buy |
| 2024-02-29 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2024-02-28 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2024-02-28 | Barclays | Maintains | Overweight -> Overweight |
| 2024-02-28 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-11-20 | Goldman Sachs | Initiate | Neutral |
| 2023-11-10 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-09-11 | Guggenheim | Maintains | Buy -> Buy |
| 2023-08-14 | Guggenheim | Reiterate | Buy -> Buy |
| 2023-08-11 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-07-26 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-07-18 | William Blair | Initiate | Outperform |
| 2023-06-26 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-06-16 | Guggenheim | Maintains | Buy |
| 2023-05-18 | Guggenheim | Initiate | Buy |
| 2023-05-08 | Oppenheimer | Reiterate | Outperform |
| 2023-03-15 | HC Wainwright & Co. | Reiterate | Buy |
| 2022-08-01 | Barclays | Initiate | Overweight |
| 2021-12-21 | HC Wainwright & Co. | Initiate | Buy |
| 2021-11-23 | Oppenheimer | Initiate | Outperform |
| 2021-10-08 | Raymond James | Maintains | Strong Buy |
| 2021-06-29 | Raymond James | Maintains | Strong Buy |